Cargando…
Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges
The SARS-CoV-2 virus has spread worldwide to cause a full blown pandemic since 2020. To date, several promising synthetic therapeutics are repurposed and vaccines through different stages of clinical trials were approved and being administered, but still the efficacy of the drugs and vaccines are ye...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390070/ https://www.ncbi.nlm.nih.gov/pubmed/34448061 http://dx.doi.org/10.1007/s00284-021-02639-x |